Systemic lupus erythematosus

• Subcutaneous Anifrolumab in Adult Patients with Systemic Lupus Erythematosus Recruitment ended
  2024-513031-24-00 10 2021-10-22 "Moderate-to-severe Systemic Lupus Erythematosus (SLE)"
• A study to learn if dapirolizumab pegol is safe and works long-term in people with systemic lupus erythematosus Recruitment ended
  2023-506368-14-00 5 2021-09-07 "Systemic lupus erythematosus (SLE)"
• Study of CC-97540 (BMS-986353), CD19-CAR T Cells, in Participants with Active SLE Despite Immunosuppressants (Breakfree-SLE) Halted
  2024-519278-37-00 4 2025-10-22 "Lupus Nephritis"
• A Phase 1 Study of CD19-targeted NEX-T CAR T Cells in Participants with Severe, Refractory Autoimmune Diseases (Breakfree-1) Halted
  2023-503823-24-01 3 2024-04-15 "Systemic Sclerosis"
• The CALiPSO-1 Study: A Study of CNTY-101, a CD19-targeted CAR iNK Cell Product, in Participants with Refractory B cell-mediated Autoimmune D … Ended
  2024-518797-13-00 3 2025-07-10 "systemic lupus erythematosus [SLE]/lupus nephritis [LN], idi"
• Multiple Ascending Doses of BMS-986326 in Participants with Discoid Lupus Erythematosus, Subacute Cutaneous Lupus Erythematosus, or Systemic … Ended
  2022-503009-39-00 3 2024-06-04 "Subacute Cutaneous Lupus Erythematosus"
• A Phase 1b Study of Imvotamab in Severe Systemic Lupus Erythematosus Ended
  2023-506499-29-00 3 2024-02-28 "Systemic Lupus Erythematosus"
• A study evaluating the effects of GLPG3667 given as oral treatment in adults with active systemic lupus erythematosus. Ended
  2023-503183-16-00 4 2024-01-16 "Systemic Lupus Erythematosus"
• A Phase 2 Multicenter Study to Evaluate PF-06823859 in Adult Participants With Active CLE or SLE With Cutaneous Manifestations Ended
  2023-503343-33-00 4 2023-12-21 "Active Cutaneous Lupus Erythematosus (CLE) or Systemic Lupus"
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Partici … Ended
  2023-509188-26-00 3 2022-10-27 "Systemic Lupus Erythematosus (SLE)"
• A study of belimumab in children with systemic lupus erythematosus (SLE) Ended
  2023-509413-37-00 4 2020-01-17 "Systemic Lupus Erythematosus"
• Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy (PLUTO) Ended
  2024-512730-15-00 4 2012-09-14 "Systemic Lupus Erythematosus"
• A study evaluating the safety, tolerability, and efficacy of GLPG5101 in adults with treatment-refractory active systemic lupus erythematosu … Ended
  2023-504422-19-00 3 "Treatment-refractory active systemic lupus erythematosus"

Showing 49–61 of 61 trials